Qinqin Xu
Xining, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Synergistic Antitumor Efficacy of Radiofrequency Ablation Combined With TROP2-CAR-T Cells in a Xenograft Mouse Model of Lung Adenocarcinoma.
Journal: Thoracic cancer
Published: January 08, 2026
Efficacy and biomarker exploration of anlotinib plus penpulimab in second-line ES-SCLC: Results from the phase 2 ALTER-L041 trial.
Journal: Cell reports. Medicine
Published: January 07, 2026
Circadian rhythms and lung cancer biology and immunotherapy: Emerging opportunities and challenges.
Journal: Chinese medical journal pulmonary and critical care medicine
Published: January 06, 2026
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial.
Journal: Cell reports. Medicine
Published: October 21, 2025
PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial.
Journal: Nature communications
Published: September 13, 2025
Tumor immune microenvironment score predicts efficacy of immune checkpoint inhibitors-based regimens in advanced non-small cell lung cancer.
Journal: Journal of translational medicine
Published: August 14, 2025
Prognostic implications of uncommon EGFR exon 19 deletion-insertion mutations in non-small cell lung cancer treated with third-generation EGFR-TKIs.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 30, 2025
Clinical Outcomes of Patients With Advanced ALK-Rearranged Lung Squamous Cell Carcinoma Treated With ALK Tyrosine Kinase Inhibitors.
Journal: Clinical lung cancer
Published: April 02, 2025
PTPMT1 inhibition induces apoptosis and growth arrest of human SCLC cells by disrupting mitochondrial metabolism.
Journal: Translational cancer research
Published: November 27, 2024
Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study.
Journal: EBioMedicine
Published: October 16, 2024
Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors.
Journal: Chinese medical journal
Published: October 06, 2024
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial.
Journal: Med (New York, N.Y.)
Published: August 14, 2024
Last Updated: 09/26/2026